Skip to main content

Tag: Germany

CSU Critiques Of Traffic Coalition Plan To Legalize Cannabis Meets Wide Mockery

CSU leader Markus Söder and Federal Health Minister Karl Lauterbach trade barbs over current government drug policy – which goes viral on German Twitter

It all began so innocently. Markus Söder, the leader of the “opposition” to the current parties comprising the Traffic Light Coalition, threw a weighted barb at the government’s drug policy during the CDU party congress in Hanover last weekend. Söder claimed that the legalization of cannabis would automatically lead to the legalization of drugs such as crystal methamphetamine (a highly addictive and dangerous street drug).

There were two problems with the approach. The first is that one of the parties now making up the coalition government, the Greens, did call for the legalization of “party drugs,” specifically cocaine, ecstasy, and amphetamines – but not crystal meth – in August. This is, however, not in the platform of the Traffic Light Coalition – which is only planning to legalize cannabis. A draft bill is expected to be made public either at the end of this year or early in 2023.

The second however, no doubt prompted by the above inaccuracies, was that Söder mispronounced the name of the drug – and instead, referred to the drug as “crystal mett.”

And this set off a rapid fire, and often humorous response.

Social Media Mockery

It was not only Lauterbach who mocked the mispronouncement on Twitter. His response? “Despite the scathing criticism from Markus Söder that the legalization of cannabis promotes the use of Crystal-Mett, we will not slow down on the same. At least vegetarians will remain safe.” Lauterbach was making a pun connecting the mispronunciation of the name of the drug to the German word for a chopped raw meat spread, frequently served with onions on bread.

This in turn set off an imaginative interchange where German Twitter users posted multiple pictures of what a “meat drug” might look like – or how it might be consumed.

This particularly imaginative response showing an addict applying heat to a spoonful of the referenced meat spread and then injecting it directly into his veins is entitled “The really hard stuff.”

The responses – both from the Health Minister and the Twitterverse seem to reflect the fact that Germans are rapidly warming to the idea of recreational cannabis reform – especially as the majority of the country is behind medical use.

This is a very good sign for the passage of full cannabis legalization sometime in the next 18-24 months aus Deutschland.

German Poll: More Than 60 Percent Support Cannabis Legalization

Germany is in the midst of a cannabis legalization effort that is more complicated and robust than anything that has ever occurred since the dawn of cannabis prohibition so many decades ago. After the dust settled on Germany’s last federal election in 2021, the incoming coalition government announced plans to move Germany toward launching a regulated adult-use cannabis industry. The current governing German coalition, commonly referred to as the ‘Traffic Light Coalition,’ has worked since late 2021 to explore various public policy components of legalization. According to the results of a new poll from Ipsos, a strong majority of Germans support the effort.

Per Ipsos‘ news release announcing the results of the poll, “61 percent of those surveyed say they would support the controlled sale of cannabis in licensed stores. Only 39 percent consider the plans to legalize cannabis to be irresponsible and fundamentally reject legal sale and consumption.” The survey was conducted online between September 2 and 4, 2022, and involved 1,000 eligible voters between the ages of 18 and 75 in Germany.

Diving Into The Results

Fortunately, there’s majority support for legalization among all age categories (18-75), however, there are statistical differences between age groups. While 61% of the poll’s participants support adult-use cannabis legalization, roughly 55% of people aged 60-75 were supportive. That is quite a bit less than the level of support among poll participants that were aged 18-39 (65%). Sixty two percent of poll participants aged 40-59 years old expressed support for legalization.

The level of support for cannabis legalization does not extend to the legalization of other banned substances in Germany. When poll participants were asked if other substances should be legalized in addition to cannabis, 95% of people expressed opposition to such a public policy change. The overwhelming level of opposition was found across age groups, although younger poll participants were more likely to express support for further legalization compared to older poll participants.

Not An Easy Lift

The current general consensus for when regulated adult-use products will actually be available for legal purchase in Germany seems to be by the year 2025. After the results of the 2021 federal election in Germany became final there was hope for legalization to become a reality in 2022. However, time has proven that hope to be a bit too ambitious.

The fact of the matter is that what German lawmakers and regulators are trying to do is something that has never been done before, at least not at the same scale. Sure, Canada and Uruguay have implemented legal adult-use sales, yet those markets pale in comparison to the size and complexity of Germany’s market. Germany has a much larger population compared to Canada and Uruguay combined, and Germany’s geographical location makes things that much more complex to navigate.

I am personally hopeful that there will be multiple steps to implementing legalization in Germany. After all, there is no need to wait for sales regulations to be formulated before implementing personal possession, consumption, and cultivation provisions. Clearly, cannabis prohibition is a failed public policy in Germany and it would be wise for lawmakers to implement as many legalization provisions as possible that pertain to individual consumers prior to finalizing provisions geared towards regulated sales.

German Insurers Begin To Take New Tact On Medical Cannabis

AOK has begun a new program with German Society for Pain Medicine to decrease approval complexity, while Barmer has just issued a new digital section on its website on the medical efficacy of cannabis. Has the tide turned on insurer resistance to medical underwriting of cannabis claims?

There is clearly something afoot with German health insurers when it comes to medical cannabis this fall. Perhaps it is the change in political winds on a national level with pending draft legislation on recreational use – which will ensure that cannabis is a part of the wellness if not healthcare discussion permanently. Perhaps it is that patients have refused to stop suing their health insurers – or that doctors have not stopped prescribing.

Whatever the driver, there have been two interesting developments on the cannabis front in the past week from two of the largest statutory health insurers in Deutschland.

AOK Enters a Pilot Program to Make Approvals Easier

In a major development for German patients – initially at least in the first trial area – AOK has agreed to cooperate with the German Society for Pain Medicine. The group is comprised of doctors who are pain specialists. Last week, the group announced in an online press conference that they are calling for the approvals process for medical cannabis to be simplified. To that end, they have entered into a contract with AOK in Rheinland/Hamburg to roll out a new kind of approvals process where doctors, not the insurer or regional approver, will have the deciding voice in whether a patient can obtain medical cannabis.

This is a huge development – and will be closely watched across the rest of the country.

Barmer Issues a New Cannabis Specialty Web Presence

One of the other top three health insurers to approve cannabis claims (by number), Barmer, has also stepped into the discussion with an interesting new series of educational web pages about cannabis. It appears that it is an effort to educate patients about how to obtain the drug – and goes to great lengths to describe cannabis as a medicine of last resort. Interestingly, they also quote data gathered by the Association of Cannabis Supplying Pharmacies (or VCA) to demonstrate what kinds of patients (and conditions) cannabis was being successfully prescribed for.

The pages also specifically try to discourage patients from obtaining their cannabis from the black market and discusses the issue of cannabis withdrawal, while admitting it is less serious than other drugs.

It appears to be communication from the health insurer in response to a growing interest from their members about the drug. There is nothing on the information provided that Barmer is going to do anything differently in terms of approving claims faster – or in a different way.

The Insurance Question

Holland’s insurers stopped covering medical cannabis claims the same month that the German government agreed to proceed on such a program in 2017.

It is unlikely that such a development will occur in Germany. That said, how the legalization of recreational use cannabis will impact such coverage, but it is unlikely that insurers will be able to step out from this responsibility. There is too much evidence in Germany of medical efficacy – even if the drug remains, sadly, a drug of last resort for most and further, unbelievably difficult to access via legal, medical channels.

Debate About Cannabis Legalization Is Still Raging In Germany Despite Government Fast-Tracking Reform

Bayern’s Health Minister has appealed to the German Chancellor to stop cannabis legalization because it was “irresponsible” after Olaf Scholz declares that there is no point in delaying cannabis reform

Last Friday, Bavaria’s Health Minister Klaus Holetschek, a member of the CSU, called on the federal German Chancellor, Olaf Scholz (of the SPD) to stop plans to legalize cannabis. In a speech made in Munich, Holetschek based his arguments on a speech that the Chancellor had recently made in Magdeburg that the government will continue to press forward on legalization plans despite some evidence that per Scholz that “people suffer psychological damage” and “ruin their lives” by using cannabis. “If the Chancellor knows the major health risks of cannabis, he should now make use of his authority to issue directives and put the legalization project on hold,” Holetschek said.

The attack appears to be, beyond a direct attack on cannabis legalization specifically, a political attempt to build on citizen protests against Scholz that occurred in Magdeburg last week. These are being prompted by fears over inflation and rising energy prices, beyond generalized criticism of the leadership of the Traffic Light Coalition itself.

Regardless, Holetschek is also the most senior politician, so far, to criticize the idea of cannabis legalization.

What does this mean for German reform?

An Easy Political Target by Conservatives

There is much talk of a conservative backlash in Germany this fall as energy inflation begins to bite. That said, it is uncertain how successful this will be, particularly as the current government has been signalling all summer that it will continue to roll out a package of incentives and other help to minimize the economic pain felt by Germans. The widely praised (and used) $9 a month train tickets are just one of these initiatives. So is a $300 grant to taxpayers from German utilities to offset higher energy prices (which has already been distributed).

The fact that cannabis legalization has been apparently added to issues to criticize the current government over, by a centre-right politician who seems to be trying to score points against the ruling parties more generally, is, as a result, far from a surprise.

The attack also appears to indicate that those against cannabis reform have little evidence or political capital to expend to support the same.

That said, there is increased rumbling if not doubt among some on the ground here that the Traffic Light Coalition will achieve their goal of passing legalization legislation in the next 12 months. Reasons usually now focus on how the German government will be able to fit legalization into international treaties which specifically ban cannabis less than domestic opposition – starting with the 1961 Single Convention on Narcotics.

For that very reason, full cannabis legalization is likely to become even more of an imperative as the tripartite government coalition now consisting of authorities from Germany, Luxembourg and Malta strives to create a value that Germans can understand.

Just like help in alleviating the high cost of fuel, cannabis reform represents a tangible metric of accomplishment.

As a result, the fact that a conservative German regional political figure, in what is considered Germany’s most staid state, is trying to call the ruling government “irresponsible” (for any reason) is unlikely to gather much steam federally.

That said, it does appear that other state health departments across Germany are also in the middle of a cannabis education campaign. For example, the Frankfurt Drugs Department will be holding an online forums in early September to educate the public about the efficacy of medical cannabis in treating psychological disorders as well as discuss burning issues like the assumption of costs by insurers for cannabis treatment beyond allowing people to discuss recreational reform.

What such backlash might be a signal of, however, rather tragically, is that state officials in states like Bayern may throw a wrench in local attempts to establish dispensaries once federal reform comes, creating a patchwork of reform that varies from state to state.

German Traffic Court Association Recommends An Increase In THC Driving Limits

In a rather shocking victory, the German Traffic Court Association has recommended that legislators increase the level of THC found in blood of drivers suspected of drugged driving before being able to charge them

There has been an unbelievably surprising if not progressive victory on the recreational cannabis front in Germany this August that will certainly have long term implications. Namely, the German Traffic Court, by definition a conservative group that helps set rules on road safety, has recommended to legislators now trying to write cannabis reform legislation, that the current limits on THC levels should be raised from their current level before drivers can be charged with drugged driving.

The current limit is currently one nanogram of THC per millilitre of blood (or the smallest measurement possible). In other words, if one has inhaled any cannabis within the last 60 days, it might prohibit one from driving altogether.

Clearly this is an impossible standard. Yet unlike the police, the Traffic Court has suggested that this limit be increased, citing the impossibility of enforcement once recreational reform becomes legal.

What that limit should be, however, is another question – and further one that went unanswered by the Association.

Regardless this is a highly significant advance for reform. The Association’s recommendations are frequently used by lawmakers when crafting legislation. It is likely that this one will be too.

Driving and Cannabis Use

The entire conversation about driving and cannabis use is one that has been festering in Germany ever since 2017. Namely, patients, who are likely to have the largest concentrations of cannabis in their system but are the least likely to be “high” when driving, have been left in an uneasy legal limbo.

It appears that the Traffic Court has recognized both this, and the other large issue lurking in the room – namely how to judge if someone is impaired by weed while driving by measuring any body fluid.

Impairment from THC intoxication generally lasts no longer than five hours. The problem is finding a test that will accurately reveal if a driver was on the road within this window of time.

Blood tests, rather than hair or urine, are the go-to tests for police inquiries in drugged driving cases.

In the United States, new breathalysers are also being used in some states by the police, although their use is still not only controversial, but even the police prefer blood tests.

It is not clear how such testing would be performed in Germany post legalization.

One thing is for sure. It is far easier to recommend that the current ridiculously low limits be raised – and another to determine what those limits should be.

From Gun Bans To Driving Limits: The International War On The Rights Of Medical Cannabis Users

In the United States, the Biden Administration is in favour of banning gun ownership for medical users. In Germany, there is an ongoing debate about driving limits. Such policies rely on outdated criteria to penalize cannabis users

The push to fully and federally legalize cannabis in places like the US and Germany right now is leading to some very unfortunate (and certainly rights-infringing) regulations.

In the US, as various cannabis bills languish in both the House and Senate, and Brittney Griner cools her heels in a Russian prison for possession of less than one gram of cannabis oil, the Biden Administration is (shamefully) defending a federal gun ownership ban for medical cannabis users. The issue is now front and centre in a legal battle launched by Florida agricultural commissioner Nikki Fried (a Democrat) to challenge the same. Fried is running as a Democratic challenger to the sitting Republican governor, Ron DeSantis.

No matter how one feels about gun control, the idea of punishing a sick person who takes a certain kind of medication (which could be any medication, beyond cannabis) is highly worrying. Not to mention represents grotesque discrimination against those with disabilities requiring medication.

In Germany, with a federal government now in the process of figuring out how to craft legislation for the full legalization of cannabis, one of the most controversial aspects of the same is setting drugged driving limits. Currently, drivers are charged with drugged driving if they are caught with even one nanogram of THC in their bloodstream – the smallest measurable amount possible. Both ADAC, the German version of AAA, and the working group of Traffic Court Day, an annual and highly influential congress that recommends new driving regulations to the government, are in support of the smallest limit possible.

That said, there is beginning to be a debate here about how problematic that is for medical users – particularly as they have a continual THC presence in their blood, even if not “high.” Beyond these heavier users of course, even a light recreational user can show traces of cannabinoids in their blood up to 60 days after their last joint. While nobody wants stoned drivers on the speed limit-free Autobahn, there needs to be some kind of compromise – not to mention some kind of technology deployment to the police – which can differentiate between recent enough use to impair driving and a THC blood level that shows constant use.

No matter where this kind of debate is taking place, however, it is clear that such questions have never been answered – and any new regulations are likely to be controversial enough to end up in court. Legislators are unlikely to be able to figure this out on their own.

Minister Of Justice In Germany’s Largest State Expresses Support For Cannabis Legalization

Benjamin Limbach is the new Minister of Justice of North Rhine-Westphalia and has stated that he considers the legalization of cannabis to be a German “right”

In an encouraging development for the recreational cannabis discussion, Benjamin Limbach, the Green Party-affiliated Minister of Justice and member of the state cabinet as of June, has now publicly backed recreational reform. According to Limbach, he will help implement any law the Bundestag passes in Germany’s largest state.

This is encouraging news, particularly given the battles on the ground so far in the state also referred to as “NRW,” where the city of Dusseldorf was forced to reverse its ban on CBD just last year after losing in court.

Will There Be NIMBY Issues in Germany?

While politicians of all stripes are beginning to recognize that backing the legalization of cannabis is a winning issue, there is also no doubt that reform will also, like it has in other places, instigate more local backlashes to continue to ban the legal sales of adult-use cannabis. There may also be local bans on cultivation and manufacturing.

While cannabis legalization is increasingly popular with the public as a whole, there are still many who believe that this is not a positive development.

So far, of course, this issue has not been an issue in Germany, but that is because nothing has become concrete. In neighbouring Holland, local communities protested local cannabis cultivation farms after they had been selected in a national bid.

National Law, Local Regulations

One of the more interesting questions that has so far been left unanswered is whether local jurisdictions and municipalities will be able to ban either local production or sales once recreational reform becomes the law of the land. In California, for example, despite having a legitimate legal market since 1996 and a recreational one since 2016, there are still counties and municipalities that have banned dispensaries outright.

Given the highly emotional response to cannabis use that is still present everywhere, this is likely to become a political issue post-legalization. In the meantime, continue to expect high-ranking politicians who are in the ruling government coalition to publicly support the advance of the Traffic Light Coalition policy. For the very first time aus Deutschland at least, supporting recreational reform has become not only a political game-changer but an issue politicians will back to bolster their careers.

Germany Or The U.S.: Who Will Go First On Federal Cannabis Reform?

The Cannabis Administration and Opportunity Act introduced in the U.S. Senate in late July, removes cannabis from the Controlled Substances Act and allows states to legalize recreational cannabis. How are American developments stacking up to current events aus Deutschland?

Ironically, just two days after Burkhard Blienert addressed the International Cannabis Business Conference in Berlin about pending German reform and outlined a rough schedule for legislative passage, a cannabis reform bill was introduced in the US Senate by Senator Chuck Schumer (D-NY).

A Side By Side Comparison

While German politicians are still unwilling to unveil details of the pending legislation until later this fall, the US version is now available for review and debate. The American bill specifically proposes removing cannabis from the Controlled Substances Act – an issue still of some contention in Germany. Beyond this, it would create a tax on cannabis product sales, expunge the records of those with past cannabis convictions, and allows federal prisoners serving time for nonviolent cannabis convictions to petition for resentencing. The legislation, if passed, would also establish a national regulatory framework to protect public health and safety.

In Europe, things are still less specific, although first-of-their-kind multilateral talks have now been launched between Malta, Luxembourg, and Germany. Beyond the information gleaned from the hearings in June, European lawmakers are now considering how to proceed not only on a national but regional level.

One of the standing questions on this side of the pond is how individual countries and the region itself will handle the actual legalization itself, including removing cannabis from sovereign narcotics laws as well as regulations at the EU level. There seems to be less interest in dealing with issues like racial justice, although there will clearly be a discussion about how to handle those with both convictions and those who are currently in jail for nonviolent cannabis offenses.

The discussion about taxing cannabis based on the levels of THC found in products and plants appears, for now, to be just a European debate.

The Likely Path To Passage

Right now, the US Senate is the main battleground for cannabis reform. Various bills have passed the House over the last decade only to be shot down in the Senate. It is also unclear whether Schumer has enough bipartisan support to carry the bill through to passage this time – and whether, once also passed in the House, the reconciliation between both bills could happen before the midterm elections.

On the other hand, the German timetable for reform is more likely to create a bill that passes both the Bundestag and Bundesrat, and further on a timetable now alluded to by national politicians.

For these reasons, while it is also very plausible that both debates will drive each other, it seems that Germany (and beyond that Europe) is likely to take the plunge into recreational reform on a schedule ahead of the US.

Recapping A Historic International Cannabis Business Conference In Berlin

Whether you are a passionate cannabis enthusiast or just a passive cannabis industry observer, you are surely well aware of the fact that Germany is trending towards implementing adult-use cannabis legalization, and with it, a regulated adult-use industry. Germany may not be the first nation to pursue such a nationwide public policy and industry evolution, however, it is the most significant effort of its kind to date.

Germany is home to the fourth-largest economy on planet earth, with only the economies of the United States, China, and Japan ranking higher (as measured by GDP). Cannabis may be legal at the state level in some parts of the U.S., yet federal legalization still remains out of sight and nationwide cannabis sales are even further out of reach. China and Japan have no current plans to legalize cannabis, and for that matter, the rest of the countries on the list of ‘top ten economies on earth’ will maintain prohibition for the foreseeable future with the exception of Canada.

Canada is currently the only G-7 nation that allows regulated adult-use sales and has served as the top ‘legal cannabis economy’ on the planet since launching nationwide adult-use sales in late 2018. Once Germany launches nationwide cannabis sales, which could come as early as 2023, it will instantly take over the title of being home to the largest cannabis market in the world.

Germany’s economy is over twice the size of Canada’s economy, and the same is true when comparing the two nations’ populations. Canada only shares a physical border with one country, the United States, and many border states now have their own adult-use industries. Germany, on the other hand, shares physical borders with nine countries – the most in Europe. Barring any unforeseen policy changes, Germany will be an adult-use sales oasis in the region to a large extent, with Germany and the surrounding countries’ populations adding up to roughly a quarter billion people. The significance of legalization in Germany cannot be overstated.

Georg Wurth on stage Berlin International Cannabis Business Conference 2022

Given the context of what is going on in Germany right now, Berlin served as an amazing backdrop to the International Cannabis Business Conference which took place on July 19-20th at the Hotel Estrel. It was the fifth installment of the B2B conference in Berlin, the largest of its type in Europe, and with so much excitement about what is going on right now in Germany, it proved to be an experience of a lifetime.

The attention of virtually every member of the emerging global cannabis industry has been squarely on Germany this year, and it was very evident throughout the conference that the excitement level was off the charts with so many people finally meeting in person to discuss everything. You could really sense that everyone was eager to get back to attending events in person, to learn more about what is going on in Germany and Europe, and to share what is going on in their own respective jurisdictions.

A major theme of this year’s historic conference involved cohorts representing over 85 countries traveling to the event, creating almost a ‘United Nations of cannabis’ environment. One thing that we have always strived to do at the International Cannabis Business Conference is to connect people from all over the globe, and it was exciting to see that on full display at this year’s Berlin conference on such a grand scale.

expo floor

Germany, for obvious reasons, is a very exciting place for cannabis and what is going on there will have a butterfly effect on the rest of the world. However, there is plenty of other significant things happening elsewhere on the planet, and that was evident in much of the networking that occurred throughout the two-day B2B conference. Entrepreneurs, policymakers, investors, and industry service providers from nearly every corner of the world were comparing notes, striking deals, and discussing plans for the future.

It was very inspiring to see each and every time, and it was truly symbolic of the current state of the cannabis industry. The cannabis industry is going global. Historically, legal cannabis markets were entirely confined by national borders. Exports and imports have slowly ramped up in some nations over time, but make no mistake – the future of the cannabis industry will largely play out on the world stage and the cannabis plant is going to go mainstream at a global level in the coming years, which was talked about over and over at the Berlin conference by participants in discussions that often included representatives from multiple continents.

burkhard blienert international cannabis business conference berlin 2022

The most historic moment of the conference, and arguably the most historic moment of any cannabis conference to date, came via the day one keynote address provided by Mr. Burkhard Blienert. Mr. Blienert currently serves as Germany’s top drug policy official and is overseeing the nation’s adult-use cannabis legalization and industry implementation process. It is the first time in history that a currently-serving official at that level has ever spoken at a cannabis conference, and right in the middle of the public policy reform process no less. Hearing from Mr. Blienert in the midst of everything that is going on in Germany and Europe was truly special and an experience that attendees will no doubt cherish for years to come.

The two-day conference was packed with other world-class speakers and panels, videos of which can be found on the International Cannabis Business Conference YouTube channel. Topics for panels and presenters included, but are not limited to:

  • Ongoing activism and advocacy
  • Medical cannabis policy
  • Cannabis policy in Germany
  • Shifting cannabis policies in Europe
  • Evolving industry standards and regulations
  • Emerging markets
  • Supply chain and logistics
  • Legalization models
  • Cultivation
  • Sustainability
  • Consumer trends
  • Investing opportunities

If you have been involved in cannabis for any significant duration of time, then you know firsthand that there are certain times and places when you realize that you are in the midst of history being made. For people in attendance at the International Cannabis Business Conference B2B event in Berlin this summer, it was absolutely one of those times. The networking and learning opportunities were unmatched, and never before has such a wide array of cannabis industry representatives from so many different countries come together under one roof at the same time.

Morgan Heritage

As always, it isn’t an International Cannabis Business Conference event without an amazing after-party, and this year’s after-party was particularly epic. Multi-Grammy awarding-winning reggae band Morgan Heritage kicked off their European tour at this year’s after-party event in Berlin. They were joined on stage by reggae pioneer Rocker-T, and collectively they rocked the house. The concert in such an intimate setting was the perfect way to unwind and celebrate after networking and learning. International Cannabis Business Conference founder Alex Rogers also rocked the mic on stage with the crew for a time, proving once again that the International Cannabis Business Conference works hard and plays hard.

The International Cannabis Business Conference team is already working hard on the next conference in Berlin which is currently slated to take place June 29-30, 2023. It’s quite possible that it could be the first conference in the new adult-use legalization era in Germany, which is an extremely exciting thought. With so much going on in the emerging global cannabis industry right now, particularly in Europe, the 2023 conference in Berlin is a must-attend. We look forward to seeing you there!

canmar